Ratnakar Securities Pvt. Ltd.

TORRENT PHARMACEUTICALS LTD.

NSE : TORNTPHARMBSE : 500420ISIN CODE : INE685A01028Industry : Pharmaceuticals & DrugsHouse : Torrent

BSE2636.3045.6 (+1.76 %)

PREV CLOSE ( ) 2590.70

OPEN PRICE ( ) 2610.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1466

TODAY'S LOW / HIGH ( )2588.00 2644.00

52 WK LOW / HIGH ( )1599 2745.55

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-07 1972

Management Info

Samir Mehta - Chairman - Managing Director

Registered Office

Address Torrent House,Off Ashram Road,,
Ahmedabad,
Gujarat-380009

Phone 079-26599000

Email investorservices@torrentpharma.com

Website www.torrentpharma.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

06Mar USFDA issues EIR to Torrent Pharmaceut
The United States Food and Drug Administration (USFDA) has successfully..

05Feb Torrent Pharmaceuticals hits 52-week h
Torrent Pharmaceuticals is currently trading at Rs. 2679.90, up by 155.2..

03Feb Torrent Pharmaceuticals reports 52% ri
Torrent Pharmaceuticals has reported results for third quarter ended Dec..

02Feb Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that the Presentation on unaudited..

12Jan Torrent Pharmaceuticals informs about
Torrent Pharmaceuticals has informed that a meeting of the Board of Dire..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	2970	10520
Gross Profit	4300	15770
Operating Profit	6900	25470
Net Sales	21230	76950

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE) 827.60 (8.15%)	M.Cap ( in Cr)390.76
Mankind Pharma (BSE) 2393.90 (2.40%)	M.Cap ( in Cr)95896.87
Ajanta Pharma (BSE) 2135.80 (2.17%)	M.Cap ( in Cr)26893.07
Strides Pharma Scien (BSE) 890.20 (5.24%)	M.Cap ( in Cr)8180.91
Natural Capsules (BSE) 363.60 (12.88%)	M.Cap ( in Cr)339.93

Shareholding Pattern

	PROMOTERS	71.25%
	NON-INSTITUTION	7.36%
	MUTUAL FUNDS/UTI	4.46%
	FI/BANKS/INSURANCE	1.95%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Aditya Birla SL Pha...	7.24
WOC Pharma and Heal...	6.94
LIC MF Healthcare F...	5.23
HDFC Pharma and Hea...	4.19
Mirae Asset Healthc...	3.83
Nippon India Nifty ...	3.64

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

TORRENT PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES